{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:10:57Z","timestamp":1790863857675,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.drugalcdep.2009.03.004","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T17:19:23Z","timestamp":1242407963000},"page":"137-147","source":"Crossref","is-referenced-by-count":21,"title":["Sedative and hypothermic effects of \u03b3-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: Assessment using biotelemetry"],"prefix":"10.1016","volume":"103","author":[{"given":"Petra S.","family":"van Nieuwenhuijzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2009.03.004_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","article-title":"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users","volume":"27","author":"Abanades","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2008.02.016","article-title":"Differentiating the discriminative stimulus effects of gamma-hydroxybutyrate and ethanol in a three-choice drug discrimination procedure in rats","volume":"89","author":"Baker","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1553-2712.2003.tb00062.x","article-title":"Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model","volume":"10","author":"Bania","year":"2003","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3565(24)29607-5","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions","volume":"297","author":"Bankson","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1615\/CritRevNeurobiol.v16.i12.70","article-title":"Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs","volume":"16","author":"Barbaccia","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0028-3908(02)00026-6","article-title":"GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid","volume":"42","author":"Barbaccia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02791072.2007.10399870","article-title":"Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study","volume":"39","author":"Barker","year":"2007","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2008.08.001","article-title":"A new brain area affected by 3,4-methylenedioxymethamphetamine: a microdialysis-biotelemetry study","volume":"596","author":"Benamar","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2003.12.004","article-title":"Baclofen prevents MDMA-induced rise in core body temperature in rats","volume":"74","author":"Bexis","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-3565(25)38650-7","article-title":"Further studies of the role of hyperthermia in methamphetamine neurotoxicity","volume":"268","author":"Bowyer","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00213-004-1790-1","article-title":"Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA","volume":"173","author":"Bubar","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib12","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/sj.npp.1300859","article-title":"Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?","volume":"30","author":"Caligiuri","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.annemergmed.2004.12.013","article-title":"Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice","volume":"45","author":"Carai","year":"2005","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainresprot.2005.04.001","article-title":"Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats","volume":"15","author":"Carai","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/jpet.102.047860","article-title":"The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies","volume":"305","author":"Carter","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib17","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","article-title":"Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB","volume":"31","author":"Carter","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1527-3458.2004.tb00025.x","article-title":"A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor","volume":"10","author":"Castelli","year":"2004","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/153537020222700603","article-title":"Decrease of core body temperature in mice by dehydroepiandrosterone","volume":"227","author":"Catalina","year":"2002","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0196-0644(98)70230-6","article-title":"Clinical course of gamma-hydroxybutyrate overdose","volume":"31","author":"Chin","year":"1998","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2005.03.002","article-title":"MDMA (\u2018Ecstasy\u2019) and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats","volume":"49","author":"Clemens","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","article-title":"Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00431683","article-title":"Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat","volume":"86","author":"Colpaert","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(83)90437-7","article-title":"Naloxone pretreatment alters the local cerebral metabolic effect of gamma-hydroxybutyrate in rats","volume":"275","author":"Crosby","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn1181","article-title":"Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system","volume":"7","author":"Cruz","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.drugpo.2007.08.007","article-title":"The epidemiology of GHB and ketamine use in an Australian household survey","volume":"19","author":"Degenhardt","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2007.02.009","article-title":"Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers","volume":"173","author":"Dresen","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0024-3205(87)90563-7","article-title":"Naloxone, naltrexone and body temperature","volume":"40","author":"Eikelboom","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(96)13032-9","article-title":"Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study","volume":"218","author":"Feigenbaum","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2466\/pms.1976.43.3.875","article-title":"Relation of general activity in rats to environmental temperature","volume":"43","author":"Finger","year":"1976","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00213-003-1694-5","article-title":"Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats","volume":"173","author":"Gallate","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/BF00975049","article-title":"Higher environmental temperature-induced increase in body temperature: involvement of serotonin in GABA mediated interaction of opioidergic system","volume":"18","author":"Ghosh","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib33","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0024-3205(01)01526-0","article-title":"Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain","volume":"70","author":"Gobaille","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2004.07.006","article-title":"A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response","volume":"500","author":"Green","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.bjp.0706318","article-title":"Studies on the effect of MDMA (\u2018ecstasy\u2019) on the body temperature of rats housed at different ambient room temperatures","volume":"146","author":"Green","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neuroscience.2006.12.023","article-title":"High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)-induced Fos expression in a region-specific manner","volume":"145","author":"Hargreaves","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib37","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0022-3565(25)10159-6","article-title":"\u03b3-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities","volume":"264","author":"Hechler","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","article-title":"Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB","volume":"965","author":"Itzhak","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 7","key":"10.1016\/j.drugalcdep.2009.03.004_bib39","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00005344-198500077-00002","article-title":"Pharmacology of potent and selective S2-serotonergic antagonists","volume":"7","author":"Janssen","year":"1985","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib40","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/0006-2952(90)90581-5","article-title":"Pyretic action of low doses of gamma-hydroxybutyrate in rats","volume":"40","author":"Kaufman","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib41","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1460-9568.2003.03013.x","article-title":"Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice","volume":"18","author":"Kaupmann","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/02791072.2004.10400040","article-title":"The use of amphetamine in gamma-hydroxybutyrate overdose: a case report","volume":"36","author":"Kohrs","year":"2004","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)31515-6","article-title":"Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat","volume":"208","author":"Lettieri","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(25)31806-9","article-title":"Effects of gamma-hydroxybutyric acid on metabolic, respiratory and vasomotor activities and body temperature in rats","volume":"211","author":"Lin","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib46","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors","volume":"38","author":"Lingenhoehl","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000138648","article-title":"Cocaine and body temperature in the rat: effects of ambient temperature","volume":"40","author":"Lomax","year":"1990","journal-title":"Pharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.mppsy.2006.09.005","article-title":"Multiple substance use","volume":"5","author":"Marshall","year":"2006","journal-title":"Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1452-8","article-title":"Increased anxiety and \u201cdepressive\u201d symptoms months after MDMA (\u201cecstasy\u201d) in rats: drug-induced hyperthermia does not predict long-term outcomes","volume":"168","author":"McGregor","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib52","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.neuropharm.2004.01.002","article-title":"Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (\u201cEcstasy\u201d) in rats","volume":"46","author":"Morley","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(01)01163-3","article-title":"Gamma-hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors","volume":"430","author":"Nava","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)03020-1","article-title":"Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome","volume":"890","author":"Nisijima","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"Gamma-hydroxybutyrate\/sodium oxybate: neurobiology, and impact on sleep and wakefulness","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1542\/peds.101.6.1045","article-title":"Baclofen overdose: drug experimentation in a group of adolescents","volume":"101","author":"Perry","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0705447","article-title":"Effects of GABA agonists on body temperature regulation in GABA(B)1-\/- mice","volume":"140","author":"Queva","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib58","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1124\/jpet.106.113886","article-title":"Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine","volume":"320","author":"Raybon","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)32056-2","article-title":"Opiates and thermoregulation in mice. I. Agonists","volume":"213","author":"Rosow","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(00)00871-2","article-title":"Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine","volume":"409","author":"Sandoval","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib61","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0091-3057(83)80017-3","article-title":"Temperature responses in rats after acute and chronic administrations of caffeine","volume":"18","author":"Schlosberg","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)01503-3","article-title":"The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil","volume":"342","author":"Schmidt-Mutter","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2008.07.005","article-title":"Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats","author":"Shioda","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0741-8329(98)00053-6","article-title":"The effects of the GABA(B) agonist baclofen on the temporal and structural characteristics of ethanol intake","volume":"17","author":"Smith","year":"1999","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.08.080","article-title":"The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam","volume":"552","author":"Smith","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1528-1157.1988.tb03732.x","article-title":"\u03b3-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models","volume":"29","author":"Snead","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1528-1157.1990.tb05373.x","article-title":"\u03b3-Hydroxybutyric acid-induced seizures bear no relation to core temperature","volume":"31","author":"Snead","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib68","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.30.8.832","article-title":"Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate","volume":"30","author":"Snead","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib69","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.drugalcdep.2007.07.009","article-title":"Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB)","volume":"92","author":"Sumnall","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/09595230500295725","article-title":"Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature","volume":"24","author":"Uys","year":"2005","journal-title":"Drug Alcohol Rev."},{"issue":"Suppl. A","key":"10.1016\/j.drugalcdep.2009.03.004_bib71","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ghir.2004.03.006","article-title":"Reciprocal interactions between the GH axis and sleep","volume":"14","author":"Van Cauter","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuroscience.2008.10.011","article-title":"The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen","volume":"158","author":"van Nieuwenhuijzen","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib73","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/15563650701365818","article-title":"Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series","volume":"45","author":"Van Sassenbroeck","year":"2007","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1211\/002235703765344513","article-title":"Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects","volume":"55","author":"Van Sassenbroeck","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0024-3205(87)90414-0","article-title":"3\u2032-5\u2032 Cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone","volume":"41","author":"Vayer","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00045391-199801000-00007","article-title":"Dopamine: pharmacologic and therapeutic aspects","volume":"5","author":"Velasco","year":"1998","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2004.06.033","article-title":"The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol","volume":"1020","author":"Verty","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib78","first-page":"1169","article-title":"Methamphetamine abuse","volume":"76","author":"Winslow","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib79","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.neuropharm.2004.08.019","article-title":"Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acid B receptor (GABA)(B)R binding sites are distinctive from one another: molecular evidence","volume":"47","author":"Wu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2009.03.004_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0306-3623(88)90065-1","article-title":"GABAA and GABAB receptor sites involvement in rat thermoregulation","volume":"19","author":"Zarrindast","year":"1988","journal-title":"Gen. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T13:09:59Z","timestamp":1739106599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871609000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0376871609000830"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.03.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}